KR7128940004
KR7128940004
HanmiPharm
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 6.1T EUR | 5.35T EUR | 7T EUR | 5.73T EUR |
Enterprise Value | 6.29T EUR | 5.56T EUR | 7.28T EUR | 6.06T EUR |
Valuation Multiples | ||||
Trailing P/E | -- | 24.65x | 40.59x | 45.15x |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 3.68x | 3.23x | 4.52x | 4.96x |
Price to Book | -- | 3.81x | 5.38x | 4.59x |
EV/Revenue | 3.8x | 3.36x | 4.7x | 5.24x |
EV/EBITDA | 16.72x | 12.19x | 19.2x | 21.1x |
Price to FCF (P/FCF) | 125.17x | 29.35x | 56.74x | 188.81x |
EV/FCF | 129.06x | 30.5x | 59x | 199.55x |
FCF Yield | 0.8% | 3.41% | 1.76% | 0.53% |